Laraway Financial Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $223K | Hold |
9,209
| – | – | 0.17% | 116 |
|
2025
Q1 | $233K | Hold |
9,209
| – | – | 0.19% | 109 |
|
2024
Q4 | $244K | Sell |
9,209
-53
| -0.6% | -$1.41K | 0.19% | 104 |
|
2024
Q3 | $268K | Buy |
9,262
+1,159
| +14% | +$33.5K | 0.21% | 100 |
|
2024
Q2 | $227K | Hold |
8,103
| – | – | 0.19% | 103 |
|
2024
Q1 | $225K | Buy |
8,103
+600
| +8% | +$16.7K | 0.2% | 104 |
|
2023
Q4 | $216K | Sell |
7,503
-1,350
| -15% | -$38.9K | 0.21% | 102 |
|
2023
Q3 | $294K | Sell |
8,853
-50
| -0.6% | -$1.66K | 0.31% | 81 |
|
2023
Q2 | $327K | Sell |
8,903
-540
| -6% | -$19.8K | 0.32% | 82 |
|
2023
Q1 | $385K | Sell |
9,443
-550
| -6% | -$22.4K | 0.39% | 78 |
|
2022
Q4 | $512K | Sell |
9,993
-587
| -6% | -$30.1K | 0.54% | 62 |
|
2022
Q3 | $463K | Buy |
10,580
+170
| +2% | +$7.44K | 0.52% | 60 |
|
2022
Q2 | $546K | Sell |
10,410
-470
| -4% | -$24.7K | 0.58% | 55 |
|
2022
Q1 | $563K | Sell |
10,880
-130
| -1% | -$6.73K | 0.51% | 65 |
|
2021
Q4 | $650K | Buy |
+11,010
| New | +$650K | 0.58% | 59 |
|